Physician

Madhu Jodhani, M.D.

According to 2025 Medicare claims, Madhu Jodhani, M.D. (NPI: 1568419588) practices hematology/oncology in the Yuba City, CA market, with the plurality of this provider's patient population coming from Sutter, CA. This provider's primary affiliated billing organization is YUBA-SUTTER ONCOLOGY CENTER INC (NPI: 1629121785; TIN: 911844456) and primary practice location at 95991-5075.

Jodhani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 618 traditional Medicare patients, billed 8,306 HCPCS/CPT codes, and received $274,916 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 8,044 prescription claims across 418 beneficiaries totaling $1,761,630 in drug costs, led by Jardiance (Empagliflozin). DME data shows 226 claims. Open Payments data shows 29 records totaling $3,041. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $647,109 to $274,916. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,709,843 and ending at $1,761,630. In contrast, DME billing represents a smaller volume and rose steadily, from $6,404 to $7,225.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	887	45,653	$647,109
2016	871	32,665	$467,691
2017	652	19,906	$287,345
2018	832	39,737	$496,157
2019	907	41,035	$580,971
2020	749	23,540	$414,501
2021	699	23,664	$450,336
2022	689	10,111	$299,682
2023	651	15,206	$376,577
2024	618	8,306	$274,916

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	406	6,574	$1,709,843
2016	400	6,591	$1,667,669
2017	353	5,827	$1,206,724
2018	394	6,461	$2,405,311
2019	404	6,605	$3,240,545
2020	402	7,156	$3,294,525
2021	412	7,023	$2,535,902
2022	409	7,119	$1,996,227
2023	408	7,341	$1,906,521
2024	418	8,044	$1,761,630

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	51	274	$84,155
2016	49	146	$3,274
2017	45	146	$2,502
2018	49	205	$10,034
2019	51	251	$8,511
2020	61	282	$7,606
2021	60	302	$9,926
2022	71	242	$7,016
2023	61	266	$4,234
2024	59	226	$3,812

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	74	74	$166
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	491	1,047	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	328	1,086	$59
96372	Injection of drug or substance under skin or into muscle	107	194	$11
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	80	1,380	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	176	10,230	$178,015
Ninlaro	Ixazomib Citrate	12	336	$151,142
Januvia	Sitagliptin Phosphate	128	6,019	$99,690
Eliquis	Apixaban	69	3,907	$75,852
Tradjenta	Linagliptin	44	3,000	$43,214

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	20	$1,332
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	35	89	$765
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	16	$733
K0738	Portable gaseous oxygen system, rental; home compressor used to fill portable oxygen cylinders; includes portable containers, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	12	$413
K0001	Standard wheelchair	Y	N/R	23	$271

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$3,041	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Madhu Jodhani, M.D.?

Tedicare shows public-source Medicare data for Madhu Jodhani, M.D. (NPI 1568419588), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Madhu Jodhani, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Madhu Jodhani, M.D.?

Madhu Jodhani, M.D. is linked to YUBA-SUTTER ONCOLOGY CENTER INC (billing NPI 1629121785) in the available physician profile data.

Does Madhu Jodhani, M.D. have Open Payments data?

Madhu Jodhani, M.D. has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.